|
SESTD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.388600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.284250E-02 |
| Normal-vs-Stage2 |
1.383220E-04 |
| Normal-vs-Stage3 |
2.543600E-03 |
| Normal-vs-Stage4 |
9.423300E-03 |
| Stage1-vs-Stage2 |
4.043900E-02 |
| Stage1-vs-Stage3 |
3.973200E-01 |
| Stage1-vs-Stage4 |
4.048800E-01 |
| Stage2-vs-Stage3 |
2.179800E-01 |
| Stage2-vs-Stage4 |
3.457000E-01 |
| Stage3-vs-Stage4 |
8.716600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.363580E-02 |
| Normal-vs-AfricanAmerican |
2.564600E-01 |
| Normal-vs-Asian |
1.420050E-01 |
| Caucasian-vs-AfricanAmerican |
9.827000E-01 |
| Caucasian-vs-Asian |
7.685000E-01 |
| AfricanAmerican-vs-Asian |
8.428600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.004300E-03 |
| Normal-vs-Female |
2.176300E-03 |
| Male-vs-Female |
7.573200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.803000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.393100E-04 |
| Normal-vs-Age(61-80Yrs) |
7.50600000000157E-05 |
| Normal-vs-Age(81-100Yrs) |
8.838100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.642100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.761850E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.870400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.632400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.881400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.757200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.814800E-01 |
| Classical-VS-Follicular |
1.48280276945911E-11 |
| Classical-VS-Other |
2.548000E-01 |
| Classical-VS-Normal |
9.161800E-02 |
| Tall-VS-Follicular |
9.59329999999925E-05 |
| Tall-VS-Other |
1.146780E-01 |
| Tall-VS-Normal |
9.566200E-01 |
| Follicular-VS-Other |
4.418400E-01 |
| Follicular-VS-Normal |
9.10638231488292E-12 |
| Other-VS-Normal |
1.898190E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.13649999972299E-07 |
| Normal-vs-N1 |
5.092200E-01 |
| N0-vs-N1 |
1.184140E-02 |
|
|
